true but most of that revenue was from the clinichain contract.Q...

true but most of that revenue was from the clinichain contract.
Q on Q last Quarter was pretty miserable. From this information looks like rev will be 2-3 m for the quarter. Not too bad.
Cash Burn will be Key, last quarter was horrible but it looked like they packed expenses in that quarter that wont reappear this Q.
I would hope we land 3-4M as per guidance.
The out look for pre-sale was a little cheeky if you read it carefully. It didn't say how many presales had been achieved rather than project what it may be!!
Essentially not much new information but appreciated anyway. I hope they do a little fluff around when the pre trial units arrive.
A little slippage again on that count, they need to tighten their projections.
Lets hope the information keeps coming and we can build a little excitement around the share price. Been a long road!!